Chicago Capital, LLC Edwards Lifesciences Corp Transaction History

Chicago Capital, LLC

$3.74 Billion
Q4 2024

A detailed history of Chicago Capital, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Chicago Capital, LLC holds 18,408 shares of EW stock, worth $1.33 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

18,408

Previous 102,171 81.98%

Holding current value

$1.33 Million

Previous $6.74 Million 79.8%

% of portfolio

0.04%

Previous 0.19%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	SELL	$64.54 - $75.92 $5.41 Million - $6.36 Million	-83,763 Reduced 81.98%	18,408 $1.36 Million
Q3 2024 Oct 18, 2024	SELL	$59.7 - $93.78 $2.53 Million - $3.98 Million	-42,395 Reduced 29.33%	102,171 $6.74 Million
Q2 2024 Aug 06, 2024	SELL	$84.3 - $94.31 $182,003 - $203,615	-2,159 Reduced 1.47%	144,566 $13.4 Million
Q1 2024 Apr 15, 2024	SELL	$72.54 - $95.56 $783,794 - $1.03 Million	-10,805 Reduced 6.86%	146,725 $14 Million
Q4 2023 Jan 22, 2024	SELL	$61.71 - $77.76 $1.16 Million - $1.46 Million	-18,829 Reduced 10.68%	157,530 $12 Million
Q3 2023 Oct 25, 2023	SELL	$69.28 - $93.38 $212,204 - $286,022	-3,063 Reduced 1.71%	176,359 $12.2 Million
Q2 2023 Jul 20, 2023	SELL	$81.41 - $94.33 $81,165 - $94,047	-997 Reduced 0.55%	179,422 $16.9 Million
Q1 2023 Apr 18, 2023	SELL	$74.26 - $84.51 $19.6 Million - $22.3 Million	-263,351 Reduced 59.34%	180,419 $14.9 Million
Q4 2022 Jan 20, 2023	SELL	$68.3 - $87.44 $3.23 Million - $4.13 Million	-47,241 Reduced 9.62%	443,770 $0
Q3 2022 Oct 14, 2022	SELL	$82.37 - $107.29 $343,235 - $447,077	-4,167 Reduced 0.84%	491,011 $40.6 Million
Q2 2022 Jul 21, 2022	BUY	$86.5 - $128.27 $2.51 Million - $3.73 Million	29,062 Added 6.23%	495,178 $47.1 Million
Q1 2022 Apr 21, 2022	BUY	$101.96 - $128.34 $1.56 Million - $1.96 Million	15,255 Added 3.38%	466,116 $54.9 Million
Q4 2021 Jan 20, 2022	SELL	$106.37 - $130.68 $660,025 - $810,869	-6,205 Reduced 1.36%	450,861 $58.4 Million
Q3 2021 Oct 28, 2021	SELL	$102.91 - $122.75 $349,173 - $416,490	-3,393 Reduced 0.74%	457,066 $51.7 Million
Q2 2021 Jul 22, 2021	SELL	$83.84 - $104.76 $73,360 - $91,665	-875 Reduced 0.19%	460,459 $47.7 Million
Q1 2021 Apr 13, 2021	BUY	$78.68 - $90.67 $467,752 - $539,033	5,945 Added 1.31%	461,334 $38.6 Million
Q4 2020 Jan 25, 2021	BUY	$71.69 - $91.23 $7.71 Million - $9.81 Million	107,585 Added 30.93%	455,389 $41.5 Million
Q3 2020 Oct 13, 2020	BUY	$67.19 - $87.44 $2,015 - $2,623	30 Added 0.01%	347,804 $27.8 Million
Q2 2020 Jul 29, 2020	BUY	$57.54 - $76.95 $13.4 Million - $17.9 Million	233,180 Added 203.48%	347,774 $24 Million
Q1 2020 Apr 21, 2020	SELL	$52.41 - $81.0 $1.95 Million - $3.02 Million	-37,238 Reduced 24.53%	114,594 $21.6 Million
Q4 2019 Jan 14, 2020	SELL	$71.7 - $82.09 $268,373 - $307,262	-3,743 Reduced 2.41%	151,832 $35.4 Million
Q3 2019 Oct 29, 2019	SELL	$61.55 - $75.43 $3.5 Million - $4.29 Million	-56,876 Reduced 26.77%	155,575 $34.2 Million
Q2 2019 Jul 11, 2019	BUY	$55.74 - $64.41 $414,092 - $478,501	7,429 Added 3.62%	212,451 $39.2 Million
Q1 2019 Apr 23, 2019	SELL	$47.89 - $64.05 $211,865 - $283,357	-4,424 Reduced 2.11%	205,022 $39.2 Million
Q4 2018 Feb 11, 2019	SELL	$46.41 - $56.94 $67,016 - $82,221	-1,444 Reduced 0.68%	209,446 $32.1 Million
Q3 2018 Nov 02, 2018	BUY	$45.7 - $58.03 $1.1 Million - $1.4 Million	24,131 Added 12.92%	210,890 $36.7 Million
Q2 2018 Jul 19, 2018	BUY	$42.45 - $51.3 $2.52 Million - $3.05 Million	59,392 Added 46.63%	186,759 $27.2 Million
Q1 2018 May 09, 2018	BUY	$37.19 - $47.45 $4.74 Million - $6.04 Million	127,367 New	127,367 $17.8 Million

Others Institutions Holding EW

# of Institutions

1,355

Shares Held

468M

Call Options Held

9.76M

Put Options Held

3.89M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital, LLC with notifications on news.

Account

Chicago Capital, LLC Edwards Lifesciences Corp Transaction History